oleanolic acid has been researched along with Bone Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choy, E; Duan, Z; Hornicek, FJ; Mankin, H; Ryu, K; Susa, M; Yang, C | 1 |
| Choy, E; Duan, Z; Hornicek, FJ; Mankin, HJ; Ryu, K; Susa, M; Yang, C | 1 |
| Bai, X; Huang, M; Jia, C; Jin, D; Lu, M; Mai, Q; Wang, L; Wang, X; Xu, S; Zhang, Z; Zhao, L; Zhou, R | 1 |
| Elliott, S; Hays, E; Mayor, M; Sporn, M; Vincenti, M | 1 |
| Benbow, U; Brinckerhoff, CE; Mengshol, JA; Mix, KS; Sporn, MB; Vincenti, MP | 1 |
5 other study(ies) available for oleanolic acid and Bone Neoplasms
| Article | Year |
|---|---|
Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis.
Topics: Adolescent; Apoptosis; Biomarkers, Tumor; Bone Neoplasms; Cell Division; Cell Line, Tumor; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Immunohistochemistry; Male; Middle Aged; Oleanolic Acid; Osteosarcoma; Phosphorylation; Prognosis; Signal Transduction; STAT3 Transcription Factor; Young Adult | 2010 |
Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.
Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Apoptosis; bcl-X Protein; Bone Neoplasms; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Myeloid Cell Leukemia Sequence 1 Protein; Oleanolic Acid; Osteosarcoma; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; STAT3 Transcription Factor; Survivin; Time Factors | 2010 |
Inhibition of mTOR signaling by oleanolic acid contributes to its anti-tumor activity in osteosarcoma cells.
Topics: Apoptosis; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Humans; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Oleanolic Acid; Osteosarcoma; Proteins; TOR Serine-Threonine Kinases; Transcription Factors | 2011 |
The triterpenoid CDDO inhibits expression of matrix metalloproteinase-1, matrix metalloproteinase-13 and Bcl-3 in primary human chondrocytes.
Topics: B-Cell Lymphoma 3 Protein; Bone Neoplasms; Cell Line, Tumor; Cells, Cultured; Chondrocytes; Chondrosarcoma; Collagenases; Dose-Response Relationship, Drug; Fibroblasts; Humans; Matrix Metalloproteinase 1; Matrix Metalloproteinase 13; Matrix Metalloproteinase Inhibitors; Oleanolic Acid; Osteoarthritis; Proto-Oncogene Proteins; Synovial Membrane; Time Factors; Transcription Factors | 2003 |
A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines.
Topics: Bone Neoplasms; Cell Division; Cell Movement; Chondrosarcoma; Collagen; Collagenases; Extracellular Matrix; Gene Expression Regulation, Enzymologic; Humans; Interleukin-1; Matrix Metalloproteinase 1; Matrix Metalloproteinase 13; Oleanolic Acid; Osteoarthritis; RNA, Messenger; RNA, Nuclear; Substrate Specificity; Tumor Cells, Cultured | 2001 |